Mrs. Iris Bincovich is an experienced CEO of Innocan Pharma in healthcare and biotech, with a proven track record in the public sector, raising capital, and increasing shareholder value. Iris also has experience developing global business strategies to open and penetrate new markets. With nearly 20 years of international marketing, business development, and sales experience, she has led and managed hundreds of successful international transactions in the OTC, cosmetics, and dermatology sectors.